MedPath

Immune Characterization of Subcutaneous Adipose Tissue

Completed
Conditions
Determine Immune Cell Types in Subcutaneous Adipose Tissue
Interventions
Procedure: Liposuction/lipectomy
Registration Number
NCT02076087
Lead Sponsor
Washington University School of Medicine
Brief Summary

The overall goal of this proposal is to characterize the immune cell profile of subcutaneous abdominal adipose tissue in lean, overweight, obese and lipedema adults, and to evaluate potential associations between different adipose tissue immune cell types and metabolic profile.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
19
Inclusion Criteria
  • Women of all races and ethnicity
  • Age between 18 and 65 years
  • Body Mass Index (BMI) ≥ 18.5 kg/m²
  • Weight stable (+/- 3% during the last 2 months before enrollment)
  • Women already scheduled for above mentioned procedures
Read More
Exclusion Criteria
  • Diabetes Mellitus
  • Recent (<5 years) history of cancer (except in situ ductal breast carcinoma)
  • Chemotherapy and/or radiation therapy within 4 months before enrollment
  • Immune system diseases (i.e., autoimmune disorders, acquired immunodeficiency syndrome)
  • Pregnant or breastfeeding
  • Take any medication that might affect immune function
  • Severe organ dysfunction
  • BMI <18.5 kg/m² or size of each breast is >600 grams, if scheduled for bilateral breast reconstruction
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Normal Weight (BMI: 18.5-24.9 kg/m²)Liposuction/lipectomyLiposuction/lipectomy
Overweight (BMI: 25.0-29.9 kg/m²)Liposuction/lipectomyLiposuction/lipectomy
Obese (BMI: >30.0kg/m²)Liposuction/lipectomyLiposuction/lipectomy
Primary Outcome Measures
NameTimeMethod
Determine the types of immune cells and the relative prevalence of each type and sub-type, in subcutaneous adipose tissue of normal weight, overweight, obese and lipedema adults.intraoperative
Secondary Outcome Measures
NameTimeMethod
Determine the relationships among specific types and subtypes of immune cells, adiposity and cardiometabolic risk.Baseline

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath